Trial Outcomes & Findings for Acupuncture and Auditory Evoked Potentials (NCT NCT00333606)
NCT ID: NCT00333606
Last Updated: 2019-10-22
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
60 participants
Primary outcome timeframe
before acupuncture stimulation
Results posted on
2019-10-22
Participant Flow
This was the crossover study with 60 participants. Each participant underwent 2 conditions: verum and sham acupuncture within an interval of at least one week.
Participant milestones
| Measure |
Sham, Then Verum Acupuncture
Stimulation was applied to sham acupuncture point
|
Verum, Then Sham Acupuncture
Stimulation was applied to verum acupuncture point
|
|---|---|---|
|
Overall Study
STARTED
|
30
|
30
|
|
Overall Study
COMPLETED
|
30
|
30
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Acupuncture and Auditory Evoked Potentials
Baseline characteristics by cohort
| Measure |
Verum, Then Sham Acupuncture
n=30 Participants
verum acupuncture means stimulation of specific acupuncture points
|
Sham, Then Verum Acupuncture
n=30 Participants
Sham acupuncture means stimulation of non-specific points
|
Total
n=60 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
30 Participants
n=5 Participants
|
30 Participants
n=7 Participants
|
60 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
20 Participants
n=5 Participants
|
20 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
10 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Region of Enrollment
Germany
|
30 participants
n=5 Participants
|
30 participants
n=7 Participants
|
60 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: before acupuncture stimulationOutcome measures
| Measure |
Verum Acupuncture
n=60 Participants
Acupuncture of specific acupuncture points
Acupuncture: Body acupuncture of 1 specific point per trial session
|
Sham Acupuncture
n=60 Participants
Acupuncture of non-specific acupuncture points
Acupuncture: Body acupuncture of 1 specific point per trial session
|
|---|---|---|
|
Latencies of Auditory Evoked Potentials
|
255 ms
Standard Deviation 55
|
255 ms
Standard Deviation 55
|
SECONDARY outcome
Timeframe: 30 minVisual Analogue Scale 0-100 mm, where 0=no pain, and 100=maximal pain
Outcome measures
| Measure |
Verum Acupuncture
n=60 Participants
Acupuncture of specific acupuncture points
Acupuncture: Body acupuncture of 1 specific point per trial session
|
Sham Acupuncture
n=60 Participants
Acupuncture of non-specific acupuncture points
Acupuncture: Body acupuncture of 1 specific point per trial session
|
|---|---|---|
|
Pain Intensity
|
40 mm
Interval 10.0 to 60.0
|
20 mm
Interval 10.0 to 30.0
|
Adverse Events
Verum Acupuncture
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Sham Acupuncture
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Taras Usichenko, director of the trial
Ernst Moritz Arndt University of Greifswald
Phone: +493834865828
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place